Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
inflammatory5866 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A14691 | 29287776 | Biochim Biophys Acta Mol Basis Dis | Activin-A causes Hepatic stellate cell activation via the induction of TNFα and TGFβ in Kupffer cells. | 2017 | Details |
A14699 | 29285942 | Orv Hetil | [Non-alcoholic fatty liver disease, as a component of the metabolic syndrome, and its causal correlations with other extrahepatic diseases]. | 2017 | Details |
A14707 | 29279175 | Eur J Radiol | MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease. | 2017 | Details |
A14713 | 29276215 | Exp Anim | Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis. | 2017 | Details |
A14714 | 29274591 | Biomed Pharmacother | Extract of Citrus maxima (pummelo) leaves improve hepatoprotective activity in Wistar rats submitted to the induction of non-alcoholic hepatic steatosis. | 2017 | Details |
A14718 | 29273476 | J Hepatol | Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. | 2017 | Details |
A14727 | 29269727 | Nat Commun | Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4-MD2 complex. | 2017 | Details |
A14731 | 29268106 | J Nutr Biochem | Food components with antifibrotic activity and implications in prevention of liver disease. | 2017 | Details |
A14733 | 29266812 | Mol Nutr Food Res | Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in Mice. | 2018 | Details |
A14739 | 29264555 | J Endocr Soc | Nonalcoholic Fatty Liver Disease in Hispanic Youth With Dysglycemia: Risk for Subclinical Atherosclerosis? | 2017 | Details |
A14750 | 29255745 | GE Port J Gastroenterol | Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease. | 2016 | Details |
A14761 | 29249967 | Front Pharmacol | Psoralea corylifolia L. Attenuates Nonalcoholic Steatohepatitis in Juvenile Mouse. | 2017 | Details |
A14764 | 29249184 | Hum Exp Toxicol | Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention. | 2017 | Details |
A14768 | 29247950 | Biomed Pharmacother | Baicalin attenuates diet induced nonalcoholic steatohepatitis by inhibiting inflammation and oxidative stress via suppressing JNK signaling pathways. | 2017 | Details |
A14772 | 29247122 | FASEB J | Prostaglandin I2 suppresses the development of diet-induced nonalcoholic steatohepatitis in mice. | 2017 | Details |
A14780 | 29235656 | Br J Dermatol | Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden? | 2018 | Details |
A14782 | 29235014 | Obes Surg | Increased Bile Acid Signals After Duodenal-Jejunal Bypass Improve Non-alcoholic Steatohepatitis (NASH) in a Rodent Model of Diet-Induced NASH. | 2018 | Details |
A14793 | 29229391 | Biochem Biophys Res Commun | Hepatocyte-specific clusterin overexpression attenuates diet-induced nonalcoholic steatohepatitis. | 2017 | Details |
A14801 | 29225114 | Prog Cardiovasc Dis | Fructose-induced inflammation and increased cortisol: A new mechanism for how sugar induces visceral adiposity. | 2017 | Details |
A14815 | 29222421 | Sci Rep | The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
A14816 | 29222051 | Biochem Biophys Res Commun | Long-term fermented soybean paste improves metabolic parameters associated with non-alcoholic fatty liver disease and insulin resistance in high-fat diet-induced obese mice. | 2017 | Details |
A14817 | 29221950 | Eur J Pharmacol | DHA supplementation prevent the progression of NASH via GPR120 signaling. | 2017 | Details |
A14827 | 29216278 | PLoS One | Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis. | 2017 | Details |
A14834 | 29212576 | Gene Expr | The Effects of Physical Exercise on Fatty Liver Disease. | 2017 | Details |
A14843 | 29209107 | World J Gastroenterol | Functional interaction of endoplasmic reticulum stress and hepatitis B virus in the pathogenesis of liver diseases. | 2017 | Details |
A14858 | 29201931 | ACG Case Rep J | Colchicine-Induced Hepatotoxicity. | 2017 | Details |
A14860 | 29201787 | Euroasian J Hepatogastroenterol | Probiotic Therapy in Patients with Nonalcoholic Steatohepatitis in Zagazig University Hospitals. | 2017 | Details |
A14861 | 29201200 | Exp Ther Med | Effect of a stilbene glycoside-rich extract from Polygoni Multiflori Radix on experimental non-alcoholic fatty liver disease based on principal component and orthogonal partial least squares discriminant analysis. | 2017 | Details |
A14865 | 29200733 | Pharmacogn Mag | Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats. | 2017 | Details |
A14866 | 29199584 | Int J Med Mushrooms | Anti-Inflammation and Lipogenic Inhibition of Taiwanofungus salmonea Mycelium and Grifola frondosa Fruiting Body. | 2017 | Details |
A14869 | 29198531 | J Pediatr | Laparoscopic Sleeve Gastrectomy Improves Nonalcoholic Fatty Liver Disease-Related Liver Damage in Adolescents by Reshaping Cellular Interactions and Hepatic Adipocytokine Production. | 2017 | Details |
A14881 | 29193575 | Liver Int | Ethanol-mediated suppression of IL-37 licenses alcoholic liver disease. | 2017 | Details |
A14887 | 29190550 | J Nutr Biochem | Green tea extract protects against hepatic NFκB activation along the gut-liver axis in diet-induced obese mice with nonalcoholic steatohepatitis by reducing endotoxin and TLR4/MyD88 signaling. | 2017 | Details |
A14891 | 29189176 | Rev Recent Clin Trials | The Emerging Role of Complement C3 as A Biomarker of Insulin Resistance and Cardiometabolic Diseases: Preclinical and Clinical Evidence. | 2018 | Details |
A14906 | 29179698 | BMC Gastroenterol | Fast food diet-induced non-alcoholic fatty liver disease exerts early protective effect against acetaminophen intoxication in mice. | 2017 | Details |
A14907 | 29179679 | BMC Gastroenterol | Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift. | 2017 | Details |
A14917 | 29175182 | Food Chem Toxicol | Impact of diesel exhaust exposure on the liver of mice fed on omega-3 polyunsaturated fatty acids-deficient diet. | 2017 | Details |
A14940 | 29164820 | Liver Int | Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models. | 2017 | Details |
A14951 | 29158819 | Theranostics | Pro-Inflammatory CXCR3 Impairs Mitochondrial Function in Experimental Non-Alcoholic Steatohepatitis. | 2017 | Details |
A14956 | 29158052 | Life Sci | Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice. | 2017 | Details |
A14957 | 29156529 | Biomed Pharmacother | Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism. | 2017 | Details |
A14958 | 29156528 | Biomed Pharmacother | Actein ameliorates hepatic steatosis and fibrosis in high fat diet-induced NAFLD by regulation of insulin and leptin resistant. | 2017 | Details |
A14959 | 29155718 | J Vis Exp | The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury. | 2017 | Details |
A14965 | 29152605 | Hepatol Commun | Hepatic Natural Killer T-cell and CD8+ T-cell Signatures in Mice with Nonalcoholic Steatohepatitis. | 2017 | Details |
A14968 | 29151501 | Intern Med | The Efficacy of Corticosteroid Therapy in a Patient with Non-alcoholic Steatohepatitis Overlapping Autoimmune Hepatitis. | 2017 | Details |
A14984 | 29141573 | Endocr Metab Immune Disord Drug Targets | Liver Protective Effects of Extra Virgin Olive Oil: Interaction between Its Chemical Composition and the Cell-signaling Pathways Involved in Protection. | 2018 | Details |
A14985 | 29139555 | Br J Pharmacol | Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease. | 2018 | Details |
A14992 | 29133512 | Diabetes | Exosomes From Adipose-Derived Stem Cells Attenuate Adipose Inflammation and Obesity Through Polarizing M2 Macrophages and Beiging in White Adipose Tissue. | 2017 | Details |
A14999 | 29129819 | Metabolism | Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease. | 2017 | Details |
A15010 | 29128059 | Clin Liver Dis | Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. | 2017 | Details |
A15035 | 29122694 | J Hepatol | Pharmacotherapy for NASH: Current and emerging. | 2017 | Details |
A15042 | 29121675 | PLoS One | Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice. | 2017 | Details |
A15054 | 29117763 | Toxicol Mech Methods | Pilose antler peptide attenuates high-fat-diet-induced liver injury. | 2017 | Details |
A15064 | 29113135 | Nutrients | Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis. | 2017 | Details |
A15079 | 29106945 | Metabolism | Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease. | 2017 | Details |
A15082 | 29106066 | J Dig Dis | Pharmacotherapy of nonalcoholic steatohepatitis: Reflections on the existing evidence. | 2017 | Details |
A15083 | 29104811 | Liver Res | Bile acid metabolism and signaling in liver disease and therapy. | 2017 | Details |
A15084 | 29104641 | Exp Ther Med | Targeting Sirt1 in a rat model of high-fat diet-induced non-alcoholic fatty liver disease: Comparison of Gegen Qinlian decoction and resveratrol. | 2017 | Details |
A15085 | 29104232 | Antioxidants (Basel) | Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes. | 2017 | Details |
A15092 | 29100781 | Steroids | Estrogens and female liver health. | 2017 | Details |
A15097 | 29098111 | Liver Res | Bile acid receptors link nutrient sensing to metabolic regulation. | 2017 | Details |
A15101 | 29095942 | PLoS One | Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease. | 2017 | Details |
A15103 | 29093267 | JCI Insight | Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH. | 2017 | Details |
A15121 | 29085434 | Evid Based Complement Alternat Med | Effect of Seyoeum on Obesity, Insulin Resistance, and Nonalcoholic Fatty Liver Disease of High-Fat Diet-Fed C57BL/6 Mice. | 2017 | Details |
A15122 | 29085222 | World J Gastroenterol | Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction. | 2017 | Details |
A15134 | 29080393 | Rom J Intern Med | Lipid profile pattern in pediatric overweight population with or without NAFLD in relation to IDF criteria for metabolic syndrome: a preliminary study. | 2018 | Details |
A15137 | 29079763 | Sci Rep | Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death. | 2017 | Details |
A15140 | 29077272 | J Cell Mol Med | Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease. | 2017 | Details |
A15141 | 29077210 | Hepatology | Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver. | 2018 | Details |
A15146 | 29074725 | Gut | Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice. | 2017 | Details |
A15154 | 29072011 | Zhen Ci Yan Jiu | [Effect of Electroacupunctrue Stimulation at "Fenglong"(ST 40) on Expression of SREBP-1 c in Non-alcoholic Fatty Liver Disease Rats]. | 2017 | Details |
A15157 | 29069580 | Eur J Pharmacol | Nicotinamide prevents sweet beverage-induced hepatic steatosis in rats by regulating the G6PD, NADPH/NADP+ and GSH/GSSG ratios and reducing oxidative and inflammatory stress. | 2017 | Details |
A15161 | 29067068 | Pak J Med Sci | Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients. | 2020 | Details |
A15167 | 29065507 | Nutrients | Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated Disorders. | 2017 | Details |
A15176 | 29063072 | Chronic Dis Transl Med | Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease. | 2017 | Details |
A15177 | 29062902 | Clin Exp Hepatol | The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease. | 2017 | Details |
A15184 | 29058997 | Annu Rev Pharmacol Toxicol | Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies. | 2017 | Details |
A15194 | 29055990 | Zhonghua Gan Zang Bing Za Zhi | [Neovascularization aggravated hepatic fibrosis in combined hypoxia NASH rat model]. | 2017 | Details |
A15196 | 29055920 | Ann Hepatol | Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications. | 2018 | Details |
A15206 | 29049401 | PLoS One | Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare. | 2017 | Details |
A15213 | 29043609 | Curr HIV/AIDS Rep | The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection. | 2017 | Details |
A15217 | 29040439 | Carcinogenesis | Eicosapentaenoic acid attenuates obesity-related hepatocellular carcinogenesis. | 2018 | Details |
A15223 | 29037210 | Lipids Health Dis | A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease. | 2017 | Details |
A15224 | 29036959 | Zhonghua Nei Ke Za Zhi | [The study of liver macrophages polarization in patients with autoimmune hepatitis]. | 2017 | Details |
A15232 | 29031784 | J Ethnopharmacol | Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats. | 2017 | Details |
A15241 | 29027424 | Zhongguo Zhong Yao Za Zhi | [Research progress on therapeutic targets of active components in Chinese herbs for treatment of nonalcoholic fatty liver disease]. | 2017 | Details |
A15245 | 29025245 | Pol J Pathol | Hepatic chemerin mRNA in morbidly obese patients with nonalcoholic fatty liver disease. | 2017 | Details |
A15247 | 29024899 | Biomed Pharmacother | Mangiferin ameliorates fatty liver via modulation of autophagy and inflammation in high-fat-diet induced mice. | 2017 | Details |
A15253 | 29023387 | Nutrients | Combination of β-glucan and Morus alba L. Leaf Extract Promotes Metabolic Benefits in Mice Fed a High-Fat Diet. | 2017 | Details |
A15269 | 28993156 | Diabetes Res Clin Pract | Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals. | 2017 | Details |
A15270 | 28993096 | Transl Res | Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells. | 2017 | Details |
A15275 | 28990215 | J Ultrasound Med | Ultrasonic Perfluorohexane-Loaded Monocyte Imaging: Toward a Minimally Invasive Technique for Selective Detection of Liver Inflammation in Fatty Liver Disease. | 2017 | Details |
A15276 | 28989978 | NPJ Precis Oncol | The therapeutic potential of resveratrol: a review of clinical trials. | 2017 | Details |
A15281 | 28988798 | Free Radic Biol Med | Differential carbonylation of proteins in end-stage human fatty and nonfatty NASH. | 2017 | Details |
A15286 | 28986720 | Curr Atheroscler Rep | The Role of Metabolic Surgery in Non-alcoholic Steatohepatitis Improvement. | 2017 | Details |
A15293 | 28982243 | J Agric Food Chem | Solanum nigrum Polyphenol Extracts Inhibit Hepatic Inflammation, Oxidative Stress, and Lipogenesis in High-Fat-Diet-Treated Mice. | 2017 | Details |
A15304 | 28973532 | Toxicol Sci | Editor's Highlight: PCB126 Exposure Increases Risk for Peripheral Vascular Diseases in a Liver Injury Mouse Model. | 2017 | Details |
A15308 | 28972487 | Georgian Med News | EFFECT THE CARDIOMETABOLIC RISK FACTORS ON VASCULAR AGING IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE CONCOMITANT WITH SUBCLINICAL HYPOTHYROIDISM. | 2017 | Details |
A15312 | 28971098 | Front Nutr | The Nutraceutic Silybin Counteracts Excess Lipid Accumulation and Ongoing Oxidative Stress in an In Vitro Model of Non-Alcoholic Fatty Liver Disease Progression. | 2017 | Details |
A15314 | 28970532 | Sci Rep | Blood-derived macrophages prone to accumulate lysosomal lipids trigger oxLDL-dependent murine hepatic inflammation. | 2017 | Details |